[lin_video src=http://eplayer.clipsyndicate.com/embed/player.js?aspect_ratio=16×9&auto_next=1&auto_start=0&div_id=videoplayer-1372804992&height=360&page_count=5&pf_id=9620&show_title=1&va_id=4125226&width=640&windows=2 service=syndicaster width=640 height=360 div_id=videoplayer-1372804992 type=script]
GARNER, IA – A newly approved drug may soon be an answer for some post menopausal symptoms.
The Food and Drug Administration gave the green light to the medicine as an alternative option for women experiencing hot flashes.
It’s called Brisdelle and has been used for years among doctors as a treatment for depression but now can be used in low doses to treat hot flashes.
According to one physician, it’s a long-awaited relief for a mysterious condition.
“We don’t perfectly understand why hot flashes happen, it’s hard to understand exactly why the drug is working the way it is. The drug works on Serotonin in the brain and we think that because it is increasing Serotonin levels, it’s helping with some temperature regulation and helping reduce some of the hot flashes,” said Jamie Brantner, Physician Assistant with Garner Medical Clinic.
Women who suffer from breast cancer or cardiovascular disease sometimes aren’t candidates for these types of treatments but according to Brantner, this is a safe alternative for them to use.
“The nice thing about the new drug that’s being released is that it is from the class of SSRI’s that we already use to treat depression and anxiety in adults. So for that reason the FDA is likely more willing to pass that because they know that the drug is safe,” said Brantner.
Doctors say that 75 percent of women suffer from hot flashes between the ages of 45 and 55.
Their hope is that the majority of women who are menopausal will benefit from the treatment to reduce the effects and frequency of hot flashes.